Reference
Shah R, et al. Evaluation of the safety and tolerability of rapid infusion of biosimilar rituximab Truxima - The University College London Hospitals (UCLH) experience. Blood 130 (Suppl. 1): 3387, Dec 2017 [abstract] - UnitedKingdom
Rights and permissions
About this article
Cite this article
Rituximab. Reactions Weekly 1695, 325 (2018). https://doi.org/10.1007/s40278-018-44152-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44152-x